Intraoperative indocyanine green fluorescence for precise resection of nonocclusive mesenteric ischemia: a case

Akihito Mizukami1, Shinji Furuya2, Koichi Takiguchi1

  • 1First Department of Surgery, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.

Surgical Case Reports
|October 4, 2024
PubMed
Abstract

Insights

This case study shows how indocyanine green (ICG) fluorescence successfully guided the precise resection of nonocclusive mesenteric ischemia (NOMI). ICG fluorescence is valuable for assessing bowel ischemia extent and improving surgical outcomes in NOMI patients.

Area of Science:

  • Gastroenterology
  • Surgical Innovation
  • Medical Imaging

Background:

  • Nonocclusive mesenteric ischemia (NOMI) is a critical condition involving intestinal ischemia due to vascular spasms, potentially leading to fatal outcomes if diagnosis and treatment are delayed.
  • While indocyanine green (ICG) fluorescence is recognized for assessing intestinal viability in NOMI surgery, documented cases are scarce.
  • This report details a successful NOMI management using accurate diagnosis and ICG-guided resection.

Purpose of the Study:

  • To present a case of NOMI successfully managed with intraoperative indocyanine green (ICG) fluorescence guidance.
  • To emphasize the utility of ICG fluorescence in accurately assessing the extent of bowel ischemia and guiding surgical resection in NOMI.

Main Methods:

  • An 81-year-old male patient presented with abdominal pain, diagnosed with NOMI based on CT findings including portal and mesenteric vein gas.
  • Emergency surgery was performed, where intraoperative ICG fluorescence identified varying degrees of intestinal hypoperfusion.
  • Resection of the affected small bowel was performed, guided by ICG findings, and a second-look operation was deemed unnecessary due to favorable postoperative recovery.

Main Results:

  • ICG fluorescence effectively differentiated areas of normal perfusion from mild and moderate hypoperfusion in the ischemic bowel.
  • Histopathological analysis confirmed mucosal edema in mildly hypoperfused areas and mucosal necrosis in moderately hypoperfused segments.
  • The patient experienced a successful recovery without signs of residual bowel ischemia, validating the ICG-guided surgical approach.

Conclusions:

  • Intraoperative ICG fluorescence is a valuable tool for assessing the extent of bowel ischemia in NOMI.
  • ICG fluorescence enables precise surgical resection, significantly improving outcomes in NOMI patients.
  • Further research should focus on accumulating more cases and quantifying ICG fluorescence intensity to enhance diagnostic accuracy and clinical application in NOMI.

Related Concept Videos